Fundz

Pulse Biosciences, Inc. reported raising $5 Million in an initial SEC Form D filing, from an offering of $5 Million

PUBLIC · PLSEFeb 15, 2017

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Feb 15, 2017)

Round Type

Venture

HaywardBiotechnologyHealth CareMedicalTherapeutics

Quick answer

Pulse Biosciences, Inc. raised $5 Million in a funding round, dated February 15, 2017. Pulse Biosciences, Inc. is based in Hayward, California, United States.

How much did Pulse Biosciences, Inc. raise?
Pulse Biosciences, Inc. raised $5 Million in a funding round on February 15, 2017.
What does Pulse Biosciences, Inc. do?
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology.
Where is Pulse Biosciences, Inc. based and how big is it?
Pulse Biosciences, Inc. is based in Hayward, California, United States. Fundz records about 75 employees.
Who are the decision-makers at Pulse Biosciences, Inc?
Fundz holds 2 contacts at Pulse Biosciences, Inc., including the Director, Talent Acquisition. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Pulse Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • BeyondSpring raised $7.2M on March 21, 2017.
  • Whitehawk Therapeutics, Inc. raised $42M on March 30, 2017.
  • AliveCor, Inc. raised $30M on March 30, 2017.
  • Streamex Corp. raised an undisclosed amount on March 30, 2017.
  • XTL Biopharmaceuticals Ltd raised $2.8M (Seed) on March 29, 2017.
  • enVVeno Medical raised $194K (Seed) on March 22, 2017.

Who to call at Pulse Biosciences, Inc., and when

A new round usually means Pulse Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pulse Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pulse Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pulse Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pulse Biosciences, Inc.

Location

3957 POINT EDEN WAY

Hayward, California, United States

About

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pulse Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJohn S., Director, Talent AcquisitionSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pulse Biosciences, Inc.'s next move

See what Strategic adds

Pulse Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.